Gene ID,Symbol,Name
2560,GABRB1,gamma-aminobutyric acid (GABA) A receptor, beta 1
2562,GABRB3,gamma-aminobutyric acid (GABA) A receptor, beta 3
3586,IL10,interleukin 10
9732,DOCK4,dedicator of cytokinesis 4
151556,GPR155,G protein-coupled receptor 155
2571,GAD1,glutamate decarboxylase 1 (brain, 67kDa)
3596,IL13,interleukin 13
9228,DLGAP2,discs, large (Drosophila) homolog-associated protein 2
51725,FBXO40,F-box protein 40
285195,SLC9A9,solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9
3600,IL15,interleukin 15
5649,RELN,reelin
11281,POU6F2,POU class 6 homeobox 2
18,ABAT,4-aminobutyrate aminotransferase
10771,ZMYND11,zinc finger, MYND-type containing 11
5141,PDE4A,phosphodiesterase 4A, cAMP-specific
51733,UPB1,ureidopropionase, beta
5142,PDE4B,phosphodiesterase 4B, cAMP-specific
54806,AHI1,Abelson helper integration site 1
4128,MAOA,monoamine oxidase A
3105,HLA-A,major histocompatibility complex, class I, A
4129,MAOB,monoamine oxidase B
4642,MYO1D,myosin ID
36,ACADSB,acyl-CoA dehydrogenase, short/branched chain
23078,VWA8,von Willebrand factor A domain containing 8
551,AVP,arginine vasopressin
40,ASIC2,acid sensing (proton gated) ion channel 2
552,AVPR1A,arginine vasopressin receptor 1A
4139,MARK1,MAP/microtubule affinity-regulating kinase 1
3628,INPP1,inositol polyphosphate-1-phosphatase
27185,DISC1,disrupted in schizophrenia 1
8242,KDM5C,lysine (K)-specific demethylase 5C
3123,HLA-DRB1,major histocompatibility complex, class II, DR beta 1
1588,CYP19A1,cytochrome P450, family 19, subfamily A, polypeptide 1
5175,PECAM1,platelet/endothelial cell adhesion molecule 1
1600,DAB1,Dab, reelin signal transducer, homolog 1 (Drosophila)
4163,MCC,mutated in colorectal cancers
5187,PER1,period circadian clock 1
1610,DAO,D-amino-acid oxidase
170572,HTR3C,5-hydroxytryptamine (serotonin) receptor 3C, ionotropic
7248,TSC1,tuberous sclerosis 1
7249,TSC2,tuberous sclerosis 2
2131,EXT1,exostosin glycosyltransferase 1
596,BCL2,B-cell CLL/lymphoma 2
3676,ITGA4,integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
5728,PTEN,phosphatase and tensin homolog
100,ADA,adenosine deaminase
114788,CSMD3,CUB and Sushi multiple domains 3
94313,AUTS5,Autism, susceptibility to, 5
3690,ITGB3,integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
4204,MECP2,methyl CpG binding protein 2
5743,PTGS2,prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
4208,MEF2C,myocyte enhancer factor 2C
1137,CHRNA4,cholinergic receptor, nicotinic, alpha 4 (neuronal)
627,BDNF,brain-derived neurotrophic factor
1139,CHRNA7,cholinergic receptor, nicotinic, alpha 7 (neuronal)
1141,CHRNB2,cholinergic receptor, nicotinic, beta 2 (neuronal)
205428,C3orf58,chromosome 3 open reading frame 58
6779,STATH,statherin
8828,NRP2,neuropilin 2
3198,HOXA1,homeobox A1
8831,SYNGAP1,synaptic Ras GTPase activating protein 1
9855,FARP2,FERM, RhoGEF and pleckstrin domain protein 2
2690,GHR,growth hormone receptor
133,ADM,adrenomedullin
2697,GJA1,gap junction protein, alpha 1, 43kDa
4233,MET,MET proto-oncogene, receptor tyrosine kinase
23178,PASK,PAS domain containing serine/threonine kinase
54413,NLGN3,neuroligin 3
139411,PTCHD1,patched domain containing 1
6804,STX1A,syntaxin 1A (brain)
23705,CADM1,cell adhesion molecule 1
154,ADRB2,adrenoceptor beta 2, surface
4763,NF1,neurofibromin 1
158,ADSL,adenylosuccinate lyase
57502,NLGN4X,neuroligin 4, X-linked
7328,UBE2H,ubiquitin-conjugating enzyme E2H
9378,NRXN1,neurexin 1
3237,HOXD11,homeobox D11
7337,UBE3A,ubiquitin protein ligase E3A
192683,SCAMP5,secretory carrier membrane protein 5
686,BTD,biotinidase
5294,PIK3CG,phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
2739,GLO1,glyoxalase I
1717,DHCR7,7-dehydrocholesterol reductase
1719,DHFR,dihydrofolate reductase
4282,MIF,macrophage migration inhibitory factor (glycosylation-inhibiting factor)
5307,PITX1,paired-like homeodomain 1
6332,SCN7A,sodium channel, voltage gated, type VII alpha subunit
3265,HRAS,Harvey rat sarcoma viral oncogene homolog
3778,KCNMA1,potassium channel, calcium activated large conductance subfamily M alpha, member 1
5321,PLA2G4A,phospholipase A2, group IVA (cytosolic, calcium-dependent)
23245,ASTN2,astrotactin 2
8912,CACNA1H,calcium channel, voltage-dependent, T type, alpha 1H subunit
1745,DLX1,distal-less homeobox 1
5329,PLAUR,plasminogen activator, urokinase receptor
721,C4B,complement component 4B (Chido blood group)
1746,DLX2,distal-less homeobox 2
27347,STK39,serine threonine kinase 39
152789,JAKMIP1,janus kinase and microtubule interacting protein 1
116442,RAB39B,RAB39B, member RAS oncogene family
64221,ROBO3,roundabout guidance receptor 3
8930,MBD4,methyl-CpG binding domain 4 DNA glycosylase
57575,PCDH10,protocadherin 10
4843,NOS2,nitric oxide synthase 2, inducible
116987,AGAP1,ArfGAP with GTPase domain, ankyrin repeat and PH domain 1
4862,NPAS2,neuronal PAS domain protein 2
50944,SHANK1,SH3 and multiple ankyrin repeat domains 1
775,CACNA1C,calcium channel, voltage-dependent, L type, alpha 1C subunit
7432,VIP,vasoactive intestinal peptide
152330,CNTN4,contactin 4
54538,ROBO4,roundabout guidance receptor 4
7436,VLDLR,very low density lipoprotein receptor
1806,DPYD,dihydropyrimidine dehydrogenase
3346,HTN1,histatin 1
1812,DRD1,dopamine receptor D1
1814,DRD3,dopamine receptor D3
3351,HTR1B,5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
54551,MAGEL2,melanoma antigen family L2
3352,HTR1D,5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled
796,CALCA,calcitonin-related polypeptide alpha
2332,FMR1,fragile X mental retardation 1
3356,HTR2A,5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
3359,HTR3A,5-hydroxytryptamine (serotonin) receptor 3A, ionotropic
1312,COMT,catechol-O-methyltransferase
4897,NRCAM,neuronal cell adhesion molecule
3361,HTR5A,5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled
93986,FOXP2,forkhead box P2
6948,TCN2,transcobalamin II
4908,NTF3,neurotrophin 3
4909,NTF4,neurotrophin 4
7472,WNT2,wingless-type MMTV integration site family member 2
4915,NTRK2,neurotrophic tyrosine kinase, receptor, type 2
9013,TAF1C,TATA box binding protein (TBP)-associated factor, RNA polymerase I, C, 110kDa
2876,GPX1,glutathione peroxidase 1
9025,RNF8,ring finger protein 8, E3 ubiquitin protein ligase
554314,AUTS6,Autism, susceptibility to, 6
5443,POMC,proopiomelanocortin
324,APC,adenomatous polyposis coli
5444,PON1,paraoxonase 1
64324,NSD1,nuclear receptor binding SET domain protein 1
64326,RFWD2,ring finger and WD repeat domain 2, E3 ubiquitin protein ligase
3912,LAMB1,laminin, beta 1
2890,GRIA1,glutamate receptor, ionotropic, AMPA 1
7498,XDH,xanthine dehydrogenase
1356,CP,ceruloplasmin (ferroxidase)
9037,SEMA5A,sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A
847,CAT,catalase
26960,NBEA,neurobeachin
2898,GRIK2,glutamate receptor, ionotropic, kainate 2
7508,XPC,xeroderma pigmentosum, complementation group C
3927,LASP1,LIM and SH3 protein 1
6999,TDO2,tryptophan 2,3-dioxygenase
22871,NLGN1,neuroligin 1
2903,GRIN2A,glutamate receptor, ionotropic, N-methyl D-aspartate 2A
100188832,AUTS1,Autism, susceptibility to, 1
9568,GABBR2,gamma-aminobutyric acid (GABA) B receptor, 2
23394,ADNP,activity-dependent neuroprotector homeobox
100188314,AUTS12,autism, susceptibility to, 12
100188317,AUTS13,autism, susceptibility to, 13
2918,GRM8,glutamate receptor, metabotropic 8
26470,SEZ6L2,seizure related 6 homolog (mouse)-like 2
221035,REEP3,receptor accessory protein 3
100188816,AUTS7,Autism, susceptibility to, 7
361,AQP4,aquaporin 4
7018,TF,transferrin
57194,ATP10A,ATPase, class V, type 10A
6507,SLC1A3,solute carrier family 1 (glial high affinity glutamate transporter), member 3
100188820,AUTS11,Autism, susceptibility to, 11
30061,SLC40A1,solute carrier family 40 (iron-regulated transporter), member 1
221037,JMJD1C,jumonji domain containing 1C
367,AR,androgen receptor
53615,MBD3,methyl-CpG binding domain protein 3
85358,SHANK3,SH3 and multiple ankyrin repeat domains 3
3952,LEP,leptin
406900,MIR106B,microRNA 106b
2944,GSTM1,glutathione S-transferase mu 1
3458,IFNG,interferon, gamma
6532,SLC6A4,solute carrier family 6 (neurotransmitter transporter), member 4
11141,IL1RAPL1,interleukin 1 receptor accessory protein-like 1
2950,GSTP1,glutathione S-transferase pi 1
6535,SLC6A8,solute carrier family 6 (neurotransmitter transporter), member 8
3479,IGF1,insulin-like growth factor 1 (somatomedin C)
3481,IGF2,insulin-like growth factor 2
5020,OXT,oxytocin/neurophysin I prepropeptide
8604,SLC25A12,solute carrier family 25 (aspartate/glutamate carrier), member 12
22941,SHANK2,SH3 and multiple ankyrin repeat domains 2
5021,OXTR,oxytocin receptor
1950,EGF,epidermal growth factor
3486,IGFBP3,insulin-like growth factor binding protein 3
29091,STXBP6,syntaxin binding protein 6 (amisyn)
27044,SND1,staphylococcal nuclease and tudor domain containing 1
1959,EGR2,early growth response 2
4520,MTF1,metal-regulatory transcription factor 1
4524,MTHFR,methylenetetrahydrofolate reductase (NAD(P)H)
6573,SLC19A1,solute carrier family 19 (folate transporter), member 1
5551,PRF1,perforin 1 (pore forming protein)
100187724,DEL16P11.2,autism, susceptibility to, 14
438,ASMT,acetylserotonin O-methyltransferase
3002,GZMB,granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
54715,RBFOX1,RNA binding protein, fox-1 homolog (C. elegans) 1
282553,AUTS8,Autism, susceptibility to, 8
5054,SERPINE1,serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
26047,CNTNAP2,contactin associated protein-like 2
121278,TPH2,tryptophan hydroxylase 2
140733,MACROD2,MACRO domain containing 2
8128,ST8SIA2,ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2
26056,RAB11FIP5,RAB11 family interacting protein 5 (class I)
5067,CNTN3,contactin 3 (plasmacytoma associated)
5579,PRKCB,protein kinase C, beta
6091,ROBO1,roundabout guidance receptor 1
6092,ROBO2,roundabout guidance receptor 2
54221,SNTG2,syntrophin, gamma 2
5071,PARK2,parkin RBR E3 ubiquitin protein ligase
6095,RORA,RAR-related orphan receptor A
200150,PLD5,phospholipase D family, member 5
5080,PAX6,paired box 6
7133,TNFRSF1B,tumor necrosis factor receptor superfamily, member 1B
93664,CADPS2,Ca++-dependent secretion activator 2
2020,EN2,engrailed homeobox 2
407010,MIR23A,microRNA 23a
3557,IL1RN,interleukin 1 receptor antagonist
3558,IL2,interleukin 2
83943,IMMP2L,inner mitochondrial membrane peptidase subunit 2
3565,IL4,interleukin 4
1007,CDH9,cadherin 9, type 2 (T1-cadherin)
3567,IL5,interleukin 5
1008,CDH10,cadherin 10, type 2 (T2-cadherin)
3569,IL6,interleukin 6
5617,PRL,prolactin
5618,PRLR,prolactin receptor
2550,GABBR1,gamma-aminobutyric acid (GABA) B receptor, 1
6134,RPL10,ribosomal protein L10
2554,GABRA1,gamma-aminobutyric acid (GABA) A receptor, alpha 1
2555,GABRA2,gamma-aminobutyric acid (GABA) A receptor, alpha 2
2556,GABRA3,gamma-aminobutyric acid (GABA) A receptor, alpha 3
387577,AUTS3,Autism, susceptibility to, 3
2557,GABRA4,gamma-aminobutyric acid (GABA) A receptor, alpha 4
3069,HDLBP,high density lipoprotein binding protein
2558,GABRA5,gamma-aminobutyric acid (GABA) A receptor, alpha 5
